Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
08/23/2000 | EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
08/23/2000 | EP0711289B1 Piperazine compounds used in therapy |
08/23/2000 | CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
08/23/2000 | CN1055687C Novel piperazine carboxamides |
08/23/2000 | CN1055682C Process for preparing mesylamido-phenethylamine derivative |
08/23/2000 | CA2299119A1 A method of stabilizing and/or isolating nucleic acids |
08/22/2000 | US6107519 Amido-substituted secondary alcohol intermediates and preparation thereof |
08/22/2000 | US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
08/22/2000 | US6107329 Hypotensive agents; cardiovascular disorders |
08/22/2000 | CA2165992C Disulphides |
08/17/2000 | WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
08/17/2000 | WO2000047554A2 INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047547A2 Cycloalkyl amine compounds and uses thereof |
08/17/2000 | CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa |
08/17/2000 | CA2361428A1 Inhibitors of factor xa |
08/16/2000 | EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
08/16/2000 | EP1027328A1 Substituted anilides |
08/16/2000 | EP1026950A1 Treatment of schizophrenia with ampakines and neuroleptics |
08/16/2000 | EP0877612B1 Use of piperazine derivatives for the treatment of cognitive disorders |
08/16/2000 | EP0755374B1 Process for peptide segment condensation |
08/15/2000 | US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent |
08/15/2000 | US6103776 Phenolic amides and their use as stabilizers |
08/15/2000 | US6103720 Ketobenzamides as calpain inhibitors |
08/15/2000 | US6103719 Neurokinin-a- or neurokinin-b tachnkinin antagonistic properties; substance p antagonism; respiratory, gastrointestinal, nervous system, skin disorders; |
08/15/2000 | US6103700 Fluoro labelled anthracyclinone and anthracycline derivatives |
08/10/2000 | WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
08/10/2000 | WO2000046191A1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same |
08/10/2000 | WO2000046187A2 Antizyme modulators and their use |
08/10/2000 | WO2000046184A1 N2-phenylamidine derivatives |
08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
08/10/2000 | CA2362259A1 Antizyme modulators and their use |
08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
08/09/2000 | EP1026150A1 (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same |
08/09/2000 | EP1026149A1 Amidocarboxylic acid derivatives |
08/09/2000 | EP1025107A1 Photochromic compounds |
08/09/2000 | EP1025097A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands |
08/09/2000 | EP1025094A1 Substituted indan derivatives |
08/09/2000 | EP1025086A1 Benzamidine derivatives as factor xa inhibitors |
08/09/2000 | EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
08/09/2000 | EP1025077A1 Novel aryloxy-alkyl-dialkylamines |
08/09/2000 | EP0823068B1 Color-providing compounds |
08/09/2000 | CN1262667A Reduction of carbonyl compounds by silane in presence of zinc catalyst |
08/09/2000 | CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone |
08/09/2000 | CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds |
08/09/2000 | CN1262272A HIV proteinase inhibitor |
08/08/2000 | US6100428 Reacting optionally protected thioureas and isothioureas with amines in the presence of a nickel catalyst to form a compound comprising a guanidine; high yields, mild reaction conditions |
08/08/2000 | US6100400 Process for the preparation of esters of [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid |
08/08/2000 | US6100280 Administering a 1-(bis(fluorophenyl)alkyl)-4-(2-oxy-3-(aryl substituted amino)propyl)piperazine derivative to treat narcotic drug dependency with reduced side effects |
08/08/2000 | US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
08/08/2000 | US6100266 Hydroxamic and carboxylic acid derivatives |
08/03/2000 | WO2000044770A1 Substituted phenethylamine derivatives |
08/03/2000 | WO2000044734A1 Compounds comprising acrylate and cyclic sec.-amine functionalities |
08/03/2000 | WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors |
08/03/2000 | WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
08/03/2000 | WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
08/03/2000 | WO2000044379A2 Methods for restoring and/or enhancing accommodation in pseudo phakia |
08/03/2000 | WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists |
08/03/2000 | WO2000018750A3 Chelates comprising chinoid groups as photoinitiators |
08/03/2000 | WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
08/03/2000 | WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides |
08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
08/03/2000 | CA2359030A1 Substituted phenethylamine derivatives |
08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
08/03/2000 | CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors |
08/03/2000 | CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
08/02/2000 | EP1024134A1 Aminobutanoic acid derivatives |
08/02/2000 | EP1023356A1 Specific fluorinated ethers as reaction medium |
08/02/2000 | EP1023278A1 Process for preparing substituted pyrazine compounds |
08/02/2000 | CN1261892A Diphosphonic acid salts for treatment of osteoporsis |
08/02/2000 | CN1261883A Novel compounds |
08/02/2000 | CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
08/02/2000 | CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
08/02/2000 | CN1261795A Compounds and methods |
08/02/2000 | CN1261534A Medicinal composition containing naphthyl compound |
08/01/2000 | US6096917 Carboxy-substituted octahydrophenanthrene-oximes and hydrazones |
08/01/2000 | US6096888 Anthracyclinone derivatives and their use in amyloidosis |
08/01/2000 | US6096779 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
08/01/2000 | US6096760 Solid α-phenyl-2-piperidine acetate free base, its preparation and use in medicine |
08/01/2000 | US6096741 Oxime derivatives, hydrazone derivatives and use thereof |
08/01/2000 | US6096098 Asymmetrical bleach activators and compositions employing the same |
08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
08/01/2000 | CA2015034C Piperazine derivatives |
07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
07/27/2000 | WO2000043368A1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods |
07/27/2000 | WO2000043356A1 Novel cationic couplers and their use for oxidation dyeing |
07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | WO2000042980A1 Naphthalene cationic coupler for oxidation dyeing of keratin fiber |
07/27/2000 | WO2000042979A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
07/27/2000 | WO2000042971A2 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods |
07/27/2000 | WO2000042852A1 Compounds and methods |
07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
07/27/2000 | WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |